Medicare Enrolled
Dr. Jorge Cheirif, MD
Cardiovascular Disease · Dallas, TX
Practice pattern: Cardiac & Cardiac
— Practice combining cardiac and cardiac services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cheirif from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cheirif?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cheirif
Dr. Jorge Cheirif is a cardiovascular disease specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cheirif performed 3,665 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Cheirif received a total of $141,545 from 48 pharmaceutical and/or device companies across 508 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cheirif is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 31% volume in TX
$141,545 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,665
Medicare services
Top 31% in TX for cardiovascular disease
Not available
Unique patients (not deduplicated)
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
865 | $88 | $323 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
611 | $10 | $65 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
539 | $88 | $397 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
313 | $28 | $154 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
310 | $11 | $118 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
181 | $61 | $238 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
173 | $172 | $781 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
153 | $113 | $500 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
141 | $82 | $281 |
| 3D radiographic procedure A radiographic imaging technique that creates three-dimensional representations of internal structures. |
109 | $7 | $25 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
81 | $100 | $455 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
56 | $135 | $435 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
39 | $81 | $806 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
39 | $141 | $789 |
| New patient office visit, complex (60-74 min) | 24 | $168 | $622 |
| Perflutren lipid microspheres injection Injection of perflutren lipid microspheres, measured per milliliter. |
18 | $35 | $130 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
13 | $17 | $82 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
23.2% high complexity
18.6% medium
58.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$141,545
Total received (2018-2024)
Avg $20,221/year across 7 years
Top 4% in TX for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
508
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,824
2023
$9,141
2022
$12,687
2021
$11,491
2020
$15,986
2019
$39,669
2018
$50,746
Payments by company (2024)
Actelion Pharmaceuticals US, Inc.
$254
HEARTFLOW, INC.
$215
Boston Scientific Corporation
$187
Novartis Pharmaceuticals Corporation
$174
Merck Sharp & Dohme LLC
$172
ABIOMED
$149
Lexicon Pharmaceuticals, Inc.
$133
PFIZER INC.
$91
SCPHARMACEUTICALS INC.
$81
Esperion Therapeutics, Inc.
$59
E.R. Squibb & Sons, L.L.C.
$46
VivaQuant Inc, dba Rhythm Express
$39
CVRx, Inc.
$38
Medtronic, Inc.
$34
Janssen Pharmaceuticals, Inc
$28
Inspire Medical Systems, Inc.
$23
Novo Nordisk Inc
$20
Itamar Medical Inc
$20
Azurity Pharmaceuticals, Inc.
$18
Kiniksa Pharmaceuticals International, plc
$16
Lilly USA, LLC
$14
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$11
Top 3 companies account for 36.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$69,145
SANOFI-AVENTIS U.S. LLC
$16,084
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$13,139
Novartis Pharmaceuticals Corporation
$11,313
Regeneron Healthcare Solutions, Inc.
$11,259
AstraZeneca Pharmaceuticals LP
$9,798
Gilead Sciences, Inc.
$5,139
Abbott Laboratories
$1,252
Actelion Pharmaceuticals US, Inc.
$600
Merck Sharp & Dohme LLC
$424
PFIZER INC.
$386
Boston Scientific Corporation
$357
E.R. Squibb & Sons, L.L.C.
$288
Itamar Medical Inc
$259
Esperion Therapeutics, Inc.
$251
HEARTFLOW, INC.
$215
Amgen Inc.
$153
ABIOMED
$149
Boehringer Ingelheim Pharmaceuticals, Inc.
$140
Lexicon Pharmaceuticals, Inc.
$133
SCPHARMACEUTICALS INC.
$95
Astellas Pharma US Inc
$79
Amarin Pharma Inc.
$75
Kiniksa Pharmaceuticals, Ltd.
$66
Medtronic, Inc.
$64
Novo Nordisk Inc
$60
Bardy Diagnostics, Inc.
$56
Baxter Healthcare
$56
Philips Electronics North America Corporation
$49
United Therapeutics Corporation
$43
VivaQuant Inc, dba Rhythm Express
$39
CVRx, Inc.
$38
HeartFlow, Inc.
$32
PORTOLA PHARMACEUTICALS, INC.
$30
Merck Sharp & Dohme Corporation
$29
Daiichi Sankyo Inc.
$28
Inspire Medical Systems, Inc.
$23
MEDICOMP INC
$22
BOSTON SCIENTIFIC CORPORATION
$21
Otsuka America Pharmaceutical, Inc.
$21
Siemens Medical Solutions USA, Inc.
$20
Regeneron Pharmaceuticals, Inc.
$20
Azurity Pharmaceuticals, Inc.
$18
ARALEZ PHARMACEUTICALS US INC.
$17
Kiniksa Pharmaceuticals International, plc
$16
Noden Pharma USA Inc
$15
Lilly USA, LLC
$14
Tactile Systems Technology Inc
$13
Top 3 companies account for 69.5% of all-time payments
Associated products mentioned in payments ›
(5050) Extended Holter · (7999) SRC Undivided · ACCOLADE · ANDEXXA · Arcalyst · Artis Q · Azure · BEVYXXA · BRILINTA · Barostim Neo System · CAMZYOS · CardioMEMS HF System · Carnation Ambulatory Monitor · Corlanor · EDARBI · ELIQUIS · EMBLEM S ICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · FARXIGA · FFRct · FLEXITOUCH · FUROSCIX · General - Therapies · INJECTAFER · INSPIRE · Impella · JARDIANCE · LEQVIO · LEXISCAN · LINQ II · LifeVest · MITRACLIP · MOUNJARO · MULTAQ · Mitra Clip system · NEXLETOL · OPSUMIT · ORENITRAM · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Proclaim Family of SCS IPGs · RESONATE · Ranexa · Repatha · Rhythm Express · Rybelsus · SAMSCA · TEKTURNA · TELEPATCH CARDIAC MONITOR · TYVASO · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN Access System · WATCHMAN FLX · WINREVAIR · WatchPAT · WatchPATONE · XARELTO · ZONTIVITY
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
306
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cheirif is a cardiac & cardiac specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cheirif experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Cheirif performed 865 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Cheirif receive payments from pharmaceutical companies?
Yes. Dr. Cheirif received a total of $141,545 from 48 companies across 508 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cheirif's costs compare to other cardiologists in Dallas?
Dr. Cheirif's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cheirif) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Dallas
Browse cardiologists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology